We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals

144 hedge funds and large institutions have $2.14B invested in Agios Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 58 increasing their positions, 42 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more call options, than puts

Call options by funds: $20.6M | Put options by funds: $10.2M

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

38% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 42

3% less capital invested

Capital invested by funds: $2.21B → $2.14B (-$71.9M)

4% less funds holding

Funds holding: 150144 (-6)

20% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 25

Holders
144
Holders Change
-6
Holders Change %
-4%
% of All Funds
3.78%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
20
Increased
58
Reduced
42
Closed
25
Calls
$20.6M
Puts
$10.2M
Net Calls
+$10.4M
Net Calls Change
+$15.5M
Name Holding Trade Value Shares
Change
Change in
Stake
Asset Management One
51
Asset Management One
Japan
$3.21M +$43.1K +657 +1%
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$3.11M +$52.5K +800 +2%
CS
53
Candriam SCA
Luxembourg
$3.02M
GH
54
GAM Holding
Switzerland
$2.97M +$2.03M +31,000 +211%
California Public Employees Retirement System
55
California Public Employees Retirement System
California
$2.85M -$361K -5,500 -11%
Millennium Management
56
Millennium Management
New York
$2.69M +$2.72M +41,454 New
CC
57
Cannell & Co
New York
$2.57M -$11.8M -179,215 -82%
Deutsche Bank
58
Deutsche Bank
Germany
$2.53M -$991K -15,115 -28%
TRSOTSOK
59
Teachers Retirement System of the State of Kentucky
Kentucky
$2.23M +$242K +3,694 +12%
OPPM
60
Opus Point Partners Management
New York
$2.21M -$787K -12,000 -26%
Macquarie Group
61
Macquarie Group
Australia
$2.09M +$284K +4,331 +16%
ProShare Advisors
62
ProShare Advisors
Maryland
$2.03M +$114K +1,740 +6%
Swiss National Bank
63
Swiss National Bank
Switzerland
$1.89M
JG
64
Jefferies Group
New York
$1.73M +$1.75M +26,654 New
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$1.62M +$39.7K +605 +2%
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$1.47M +$107K +1,624 +8%
WJA
67
Williams Jones & Associates
New York
$1.36M -$455K -6,933 -25%
AQR Capital Management
68
AQR Capital Management
Connecticut
$1.33M -$202K -3,073 -13%
TAM
69
Tocqueville Asset Management
New York
$1.26M -$13.1K -200 -1%
TA
70
Teachers Advisors
New York
$1.25M +$22.6K +345 +2%
State of Wisconsin Investment Board
71
State of Wisconsin Investment Board
Wisconsin
$1.22M -$29.5K -450 -2%
BNP Paribas Financial Markets
72
BNP Paribas Financial Markets
France
$1.22M +$750K +11,443 +155%
PA
73
Profund Advisors
Maryland
$1.2M +$2.43K +37 +0.2%
Citigroup
74
Citigroup
New York
$1.14M -$717K -10,930 -38%
MOACM
75
Mutual of America Capital Management
New York
$1.13M +$5.64K +86 +0.5%

AGIO Hedge Fund Activity: Q4 2015 in Review

144 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q4 2015, worth a combined $2.14B — down 3.2% from $2.21B a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of AGIO and 20 opened new positions — a net loss of 5 holders — while 42 trimmed existing stakes and 58 added.

The largest buyer was ClearBridge Investments, adding an estimated $65.6M. The largest seller was AllianceBernstein, cutting an estimated $20.7M.

  • 144 institutional investors held Agios Pharmaceuticals (AGIO) as of Q4 2015, down from 150 in Q3 2015.
  • Funds reported $2.14B of Agios Pharmaceuticals stock for Q4 2015, down 3.2% quarter-over-quarter.
  • 20 funds opened new Agios Pharmaceuticals positions in Q4 2015 and 25 closed out, a net change of -5 holders.
  • The largest Agios Pharmaceuticals buyer in Q4 2015 was ClearBridge Investments, an estimated $65.6M added.
  • The largest Agios Pharmaceuticals seller in Q4 2015 was AllianceBernstein, an estimated $20.7M sold.

Based on aggregated 13F filings for Q4 2015.